Literature DB >> 3383024

Late progression of post-encephalitic Parkinson's syndrome.

D B Calne1, A J Lees.   

Abstract

We have studied 11 patients with neurological deficits due to the pandemic of encephalitis lethargica, all of whom had remained in hospital for more than forty years. Retrospective information obtained from physicians and nurses dating back as far as 1931, our own Webster and Northwestern University Disability Rating Scales available from 1976, photographic records, published narrative and hospital charts all indicate that neurological disabilities attributable to basal ganglia damage frequently increase in late life. Deterioration was most marked in motor function and largely spared the intellect, special senses and somatosensory system. The findings are discussed in relation to current hypotheses concerning the aetiology of Parkinson's disease.

Entities:  

Mesh:

Year:  1988        PMID: 3383024     DOI: 10.1017/s0317167100027499

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  8 in total

Review 1.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

2.  Possible clinical overlap between postencephalitic parkinsonism and progressive supranuclear palsy.

Authors:  P P Pramstaller; A J Lees; L M Luxon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 3.  Parkinson's disease.

Authors:  E C Wolters; D B Calne
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

4.  Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism.

Authors:  G K Wenning; K Jellinger; I Litvan
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  Astrocytes and therapeutics for Parkinson's disease.

Authors:  Phillip M Rappold; Kim Tieu
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

6.  Is progression in postencephalitic Parkinson's disease late and age-related?

Authors:  P Vieregge; V Reinhardt; B Höft
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

7.  The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.

Authors:  Eleanna Kara; Helen Ling; Alan M Pittman; Karen Shaw; Rohan de Silva; Roberto Simone; Janice L Holton; Jason D Warren; Jonathan D Rohrer; Georgia Xiromerisiou; Andrew Lees; John Hardy; Henry Houlden; Tamas Revesz
Journal:  Neurobiol Aging       Date:  2012-05-16       Impact factor: 4.673

8.  Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.

Authors:  Richard M Salmon; Jingxu Guo; Jennifer H Wood; Zhen Tong; John S Beech; Aleksandra Lawera; Minmin Yu; David J Grainger; Jill Reckless; Nicholas W Morrell; Wei Li
Journal:  Nat Commun       Date:  2020-04-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.